Commentary: "Noradrenergic and Serotonergic Neuroendocrine Responses in Prepubertal, Peripubertal, and Postpubertal Rats Pretreated with Desipramine and Sertraline"

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 41, Issue 8, 2002, Pages 1007-1009

  Leckman, James F ^a   Young, Christopher ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DESIPRAMINE; DOPAMINE; DOPAMINE RECEPTOR; NORADRENALIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULTHOOD; BIPOLAR DISORDER; CHILD; CYCLIC AMP RESPONSIVE ELEMENT; DEPRESSION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; HUMAN; LONG TERM CARE; MANIA; NERVOUS SYSTEM DEVELOPMENT; NEUROENDOCRINE SYSTEM; NONHUMAN; NORADRENERGIC SYSTEM; NOTE; PREPUBERTY; PRIORITY JOURNAL; PUBERTY; RAT; SEROTONINERGIC SYSTEM;

EID: 0012494498     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004583-200208000-00020     Document Type: Article

References (22)

1. Angold A, Costello EJ, Worthman CM (1999), Pubertal changes in hormone levels and depression in girls. Psychol Med 29:1043-1053
2. Carrey NJ, Dursun S, Clements R, Renton K, Waschbusch D, MacMaster FP (2002), Noradrenergic and serotonergic neuroendocrine responses in prepubertal, peripubertal, and postpubertal rats pretreated with desipramine and sertraline. J Am Acad Child Adolesc Psychiatry 41:999-1006
3. Costello EJ, Pine DS, Hammen C et al. (in press), Development and natural history of mood disorders. Biol Psychiatry
4. Duman RS, Malberg J, Thome J (1999), Neural plasticity to stress and antidepressant treatment. Biol Psychiatry 46:1181-1191
5. Emslie GJ, Rush AJ, Weinberg WA et al. (1997), A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry 54:1031-1037
6. Geller B, Zimerman B, Williams M, Bolhofner K, Craney JL (2001), Bipolar disorder at prospective follow-up of adults who had prepubertal major depressive disorder. Am J Psychiatry 158:125-127
7. Geller B, Fox L, Clark K (1994), Rate and predictors of prepubertal bipolarity during follow-up of 6- to 12-year-old depressed children. J Am Acad Child Adolesc Psychiatry 33:461-468
8. Guidotti A, Costa E (1998), Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnalone) availability? Biol Psychiatry 44:865-873
9. Huang NY, Strakhova M, Layer RT, Skolnick P (1997), Chronic antidepressant treatments increase cytochrome b mRNA levels in mouse cerebral cortex. J Mol Neurosci 9:167-176
10. Insel TR (2000), The development of brain and behavior. In: Psychopharmacology: The Fourth Generation of Progress (CD-ROM), Bloom FE, Kupfer D, eds. New York: Raven Press (published online at http://acnp.org/g4/GN401000066/ Default.htm)
11. Malberg JE, Eisch AJ, Nestler EJ, Duman RS (2000), Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus. J Neurosci 20:9104-9110
12. Manji HK, Moore GJ, Chen G (2001), Bipolar disorder: leads from the molecular and cellular mechanisms of action of mood stabilisers. Br J Psychiatry 178(suppl 41):S107-S119
13. Mundo E, Walker M, Cate T, Macciardi F, Kennedy JL (2001), The role of serotonin transporter protein gene in antidepressant-induced mania in bipolar disorder: preliminary findings. Arch Gen Psychiatry 58:539-544
14. RUPP Anxiety Study Group (2001), An eight-week placebo-controlled trial of fluvoxamine for anxiety disorders in children and adolescents. N Engl J Med 344:1279-1285
15. Silberg J, Pickles A, Rutter M et al. (1999), The influence of genetic factors and life stress on depression among adolescent girls. Arch Gen Psychiatry 56:225-232
16. Stubbe DE, Thomas WJ (2002), A survey of early-career child and adolescent psychiatrists: professional activities and perceptions. J Am Acad Child Adolesc Psychiatry 41:123-130
17. Vaccarino FM, Leckman JF (2000), Molecular neurobiology of development. In: Psychopharmacology: The Fourth Generation of Progress (CD-ROM), Bloom FE, Kupfer D, eds. New York: Raven Press (published online at http://acnp.org/g4/GN4010000080/Default.htm)
18. Walkup J, Lebellarte M (2001), Complications of SSRI treatment. J Child Adolesc Psychopharmacol 11:1-4
19. Wegerer V, Moll GH, Bagli M, Rothenberger A, Ruther E, Huether G (1999), Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life. J Child Adolesc Psychopharmacol 9:13-24
20. Yamada M, Yamada M, Yamazaki S et al. (2000), Identification of a novel gene with RING-H2 finger motif induced after chronic antidepressant treatment in rat brain. Biochem Biophys Res Commun 278:150-157
21. Zito JM, Safer DJ (2001), Services and prevention: pharmacoepidemiology of antidepressant use. Biol Psychiatry 49:1121-1127
22. Zito JM, Safer DJ, dosReis S, Gardner JF, Boles M, Lynch F (2000), Trends in the prescribing of psychotropic medications to preschoolers. JAMA 283:1025-1030